Table 1.
Frequency and Mortality Rate of HIV/AIDS Patients Who Received Antiretroviral Therapy at Orotta National Referral and Teaching Hospital and Halibet National Referral Hospital Followed Up Between 2005 and December 31, 2021 (N=3646)
| Variable | Number of Participants (%)a |
Deaths | Person-Years at Risk |
Mortality Rate per 100 Person-Years (95% CI) |
|
|---|---|---|---|---|---|
| Overall | 3646 (100) | 418 | 31,870.3 | 1.32 (1.20–1.44) | |
| Sex |
Male | 1470 (40.32) | 200 | 12,590.9 | 1.59 (1.39–1.83) |
| Female | 2176 (59.68) | 218 | 19,279.5 | 1.14 (1.00–1.30) | |
| Age |
15-30 | 919 (25.21) | 67 | 8194.1 | 0.82 (0.65–1.04) |
| 31-45 | 2099 (57.57) | 230 | 18,785.7 | 1.23 (1.08–1.40) | |
| 46 and above | 628 (17.22) | 121 | 4890.7 | 2.48 (2.08–2.96) | |
| Employment status | Employed | 1524 (42.1) | 180 | 13,703.9 | 1.32 (1.14–1.53) |
| Unemployed | 2096 (57.9) | 238 | 17,975.4 | 1.33 (1.17–1.51) | |
| Educational status | No formal education | 302 (8.37) | 37 | 2602.3 | 1.43 (1.04–1.97) |
| Primary | 912 (25.26) | 105 | 8843.6 | 1.19 (0.99–1.44) | |
| Secondary | 2191 (60.69) | 248 | 18,207.9 | 1.37 (1.21–1.55) | |
| Higher | 205 (5.68) | 23 | 2005.1 | 1.15 (0.77–1.73) | |
| Marital status |
Married | 427 (11.76) | 213 | 15,792.3 | 1.35 (1.18–1.55) |
| Divorced/Sep | 808 (22.25) | 55 | 3445.9 | 1.60 (1.23–2.08) | |
| Single | 652 (17.95) | 97 | 6048.3 | 1.61(1.32–1.96) | |
| Widowed | 1745 (48.05) | 52 | 6489.3 | 0.81(0.62–1.06) | |
| Region |
Zoba Maekel | 2715 (75.02) | 349 | 23,611.6 | 1.48 (1.34–1.65) |
| Outside Zoba Maekel | 904 (24.98) | 68 | 8102 | 0.84 (0.67–1.07) | |
| Residence |
Rural | 579 (16) | 62 | 5172.3 | 1.20 (0.94–1.54) |
| Urban | 3040 (84) | 355 | 26,541.3 | 1.34 (1.21–1.49) | |
| Baseline body weight(kg) | < 45 | 736 (20.2) | 132 | 5117.7 | 2.58 (2.17–3.06) |
| 45-60 | 1996 (54.7) | 215 | 17,349.6 | 1.24 (1.08–1.42) | |
| > 60 | 914 (25.1) | 71 | 9403.1 | 0.76 (0.60–0.95) | |
| Adherence |
Good | 3176 (87.4) | 307 | 29,088 | 1.06 (0.95–1.19) |
| Fair | 306 (8.42) | 76 | 1789.1 | 4.25 (3.4–5.32) | |
| Poor | 152 (4.18) | 35 | 879.8 | 3.98 (2.86–5.55) | |
| Baseline WHO clinical stage | Stage I&II | 1589 (43.64) | 144 | 14,329 | 1.01 (0.86–1.19) |
| Stage III&IV | 2052 (56.36) | 274 | 17,525 | 1.57 (1.39–1.77) | |
| Baseline functional status | Working | 2826 (77.62) | 245 | 25,671 | 0.96 (0.85–1.09) |
| Ambulatory | 623 (17.11) | 134 | 4472.9 | 3.00 (2.53–3.55) | |
| Bedridden | 192 (5.27) | 39 | 1710.6 | 2.29 (1.67–3.13) | |
| Baseline CD 4 count |
<=100 | 484 (13.29) | 147 | 2254.3 | 6.53 (5.55–7.67) |
| 101-200 | 492 (13.51) | 100 | 3303.4 | 3.03 (2.49–3.69) | |
| 201-350 | 747 (20.52) | 88 | 6325.9 | 1.40 (1.13–1.72) | |
| 351 and above | 1918 (52.68) | 83 | 19,958 | 0.42 (0.34–0.52) | |
Note: a Discrepancy in number is due to missing values.